Conduit Pharmaceuticals secures $1.2M in new loans; issues warrants and amends existing debt

CDT Equity Inc.

Entered Bridge Loan with A.G.P. for up to $600k at 4.21% due Dec 31, 2024; issued warrants for 2.86M shares at $0.1048 per share, subject to shareholder approval.
Issued $600k promissory note to Nirland Limited at 12% per annum, maturing Oct 31, 2025; includes 1% arrangement fee.
Amended prior $2.65M Nirland note to allow conversion to common stock and removed mandatory prepayment and right of first refusal.
Proceeds from ATM offering of up to ~$3.5M will be used first to repay the A.G.P. Bridge Note.
Warrants and conversion shares are unregistered, issued under Section 4(a)(2) exemption.

item 1.01 item 1.02 item 2.03 item 3.02 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.